Elnaz Agi
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Immunotherapy and Immune Responses
Papers in
-
- vaccines and immunoinformatics approaches 9
- RNA Interference and Gene Delivery 6
- Immunology 14
- Immunotherapy and Immune Responses 14
- Co-authors
- Azam Bolhassani (29 shared papers)Ali Namvar (5 shared papers)Seyed Mehdi Sadat (4 shared papers)Sepideh Shahbazi (3 shared papers)Rouhollah Vahabpour (3 shared papers)Noushin Davoudi (2 shared papers)Kimia Kardani (2 shared papers)Alireza Milani (9 shared papers)
- Journals
- Biotechnology Letters (3 papers)Immunology Letters (2 papers)Microbial Pathogenesis (1 paper)Journal of Pharmaceutical Sciences (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- IranUnited StatesGermany
In The Last Decade
Elnaz Agi
30 papers receiving 367 citations
Peers
Comparison fields: 5 of 73
- Virology 39
- Immunology 133
- Infectious Diseases 64
- Molecular Biology 220
- Biotechnology 27
Countries citing papers authored by Elnaz Agi
This map shows the geographic impact of Elnaz Agi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elnaz Agi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elnaz Agi more than expected).
Fields of papers citing papers by Elnaz Agi
This network shows the impact of papers produced by Elnaz Agi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elnaz Agi. The network helps show where Elnaz Agi may publish in the future.
Co-authors
The 25 scholars most cited alongside Elnaz Agi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 100 | |
| 2 | 2020 | 36 | |
| 3 | 2017 | 27 | |
| 4 | 2015 | 23 | |
| 5 | 2019 | 21 | |
| 6 | 2022 | 19 | |
| 7 | 2014 | 19 | |
| 8 | 2016 | 19 | |
| 9 | 2015 | 18 | |
| 10 | 2014 | 16 | |
| 11 | 2016 | 12 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2016 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 4 |
About Elnaz Agi
Elnaz Agi is a scholar working on Molecular Biology, Immunology, Virology, Epidemiology and Infectious Diseases, having authored 32 papers that have together received 375 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), HIV Research and Treatment (10 papers), vaccines and immunoinformatics approaches (9 papers), Hepatitis B Virus Studies (7 papers), RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers), Bacteriophages and microbial interactions (4 papers) and Transgenic Plants and Applications (4 papers). The work is most often cited by research in Virology (39 citations), Immunology (133 citations), Infectious Diseases (64 citations), Molecular Biology (220 citations) and Biotechnology (27 citations). Elnaz Agi has collaborated with scholars based in Iran, United States and Germany. Frequent co-authors include Azam Bolhassani, Ali Namvar, Seyed Mehdi Sadat, Sepideh Shahbazi, Rouhollah Vahabpour, Noushin Davoudi, Kimia Kardani, Alireza Milani, Amin Hadi and Nooshin Haghighipour. Their work appears in journals such as Biotechnology Letters, Immunology Letters, Microbial Pathogenesis, Journal of Pharmaceutical Sciences and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.